Brief: SynAct Pharma Resolves On Directed Share Issue Of 227,203 Shares
Jan 9 (Reuters) - SynAct Pharma AB SYNACT.ST :
* RESOLVES ON DIRECTED SHARE ISSUE OF 227,203 SHARES
* SUBSCRIPTION PRICE IN COMPENSATION ISSUE SET AT SEK 8.65
PER
SHARE
Source text: ID:nMFNbRHC5Y
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development